For the Inventor, By the Inventor

Enter assignee name

Cambridge, United Kingdom

Kudos Pharmaceuticals Limited

USPTO Granted Patents = 36

% Expired Patents = 33.3

CIPO Patents = 3

EPO Patents = 12

Forward Citations = 274

Loading Chart...

Loading Chart...

70 inventors (with patents filed for the assignee):

Keith Allan Menear (21 out of 32 patents)

Niall Morrison Barr Martin (20 out of 31 patents)

Graeme Cameron Murray Smith (16 out of 25 patents)

4. Stephen Philip Jackson (14 out of 18 patents)

5. Xiao-Ling Fan Cockcroft (10 out of 15 patents)

6. Graeme Cameron Smith (9 out of 10 patents)

7. Ian Timothy Williams Matthews (9 out of 10 patents)

8. Alan Ashworth (9 out of 15 patents)

9. Frank Kerrigan (9 out of 13 patents)

10. Vincent Junior M Loh (7 out of 8 patents)

11. Marc Geoffrey Hummersone (6 out of 9 patents)

12. Roger John Griffin (6 out of 20 patents)

13. Laurent Jean Martin Rigoreau (5 out of 12 patents)

14. Julie Kay Cahill (5 out of 6 patents)

15. Kieran James Lennon (5 out of 8 patents)

Core Competencies:

Phthalazinone Derivatives

mTOR Inhibitors

DNA Damage Repair

DNA-PK Inhibitors

ATM Inhibitors

Immediate Release Formulations

Cancer Therapy

Therapeutic Agents

Cellular Modulation

Pharmaceutical Compounds

Drug Formulation

Pyrimidine Derivatives

36 patents: Sort by Forward Citations

1. 12178816 - Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one (2024-12-31),

2. 12144810 - Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one (2024-11-19),

3. 12048695 - Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one (2024-07-30),

4. 11975001 - Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one (2024-05-07),

5. 11633396 - Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H- phthalazin-1-one (2023-04-25),

6. 11160803 - Phthalazinone derivatives (2021-11-02),

7. 10034884 - Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors (2018-07-31),

8. 9717736 - Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors (2017-08-01),

9. 9566276 - Phthalazinone derivatives (2017-02-14),

10. 9169235 - Phthalazinone derivatives (2015-10-27),

11. 9102670 - Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors (2015-08-11),

12. 8912187 - Phthalazinone derivatives (2014-12-16),

13. 8247416 - Phthalazinone derivative (2012-08-21),

14. 8183369 - 4- [3- (4-cyclopropanecarbonyl-piperazine-I-carbonyl) -4 -fluoro-benzyl] -2H-phthalaz in-1-one (2012-05-22),

15. 8143241 - DNA damage repair inhibitors for treatment of cancer (2012-03-27),

Company Overview

Kudos Pharmaceuticals Limited is a biotechnology company based in Cambridge, UK, specializing in the development of innovative therapeutics. The organization focuses on advancing drug discovery and formulation technologies, particularly in the fields of oncology and infectious diseases. With a commitment to addressing unmet medical needs, Kudos Pharmaceuticals leverages cutting-edge research and development practices to create effective solutions that enhance patient outcomes and contribute to the global healthcare landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

36 Patents

#29 in Cambridge

#503 in United Kingdom

#18,745 in the World

Cambridge, United Kingdom

Kudos Pharmaceuticals Limited

Forward Citations = 274

70 inventors:

Keith Allan Menear (21 out of 32 patents)

Niall Morrison Barr Martin (20 out of 31 patents)

Graeme Cameron Murray Smith (16 out of 25 patents)

4. Stephen Philip Jackson (14 out of 18 patents)

5. Xiao-Ling Fan Cockcroft (10 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kudos Pharmaceuticals Limited. Retrieved from https://idiyas.com/company/kudos-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…